Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$1.25 - $2.35 $4,643 - $8,730
-3,715 Reduced 1.61%
226,712 $489,000
Q1 2023

May 15, 2023

SELL
$2.65 - $3.81 $1.89 Million - $2.72 Million
-714,800 Reduced 75.62%
230,427 $684,000
Q4 2022

Feb 14, 2023

SELL
$3.38 - $4.22 $4.29 Million - $5.36 Million
-1,269,321 Reduced 57.32%
945,227 $3.45 Million
Q3 2022

Nov 14, 2022

BUY
$3.43 - $5.83 $1.54 Million - $2.61 Million
447,913 Added 25.35%
2,214,548 $7.97 Million
Q2 2022

Aug 10, 2022

BUY
$4.41 - $5.69 $1.58 Million - $2.04 Million
358,806 Added 25.49%
1,766,635 $9.35 Million
Q1 2022

May 16, 2022

SELL
$4.81 - $6.99 $3.07 Million - $4.46 Million
-637,916 Reduced 31.18%
1,407,829 $7.73 Million
Q4 2021

Feb 14, 2022

SELL
$5.97 - $7.93 $586,862 - $779,534
-98,302 Reduced 4.58%
2,045,745 $13.9 Million
Q3 2021

Nov 15, 2021

BUY
$4.79 - $6.68 $816,144 - $1.14 Million
170,385 Added 8.63%
2,144,047 $13.1 Million
Q2 2021

Aug 16, 2021

BUY
$5.35 - $6.35 $551,472 - $654,551
103,079 Added 5.51%
1,973,662 $11.7 Million
Q1 2021

May 14, 2021

BUY
$5.68 - $7.87 $4.74 Million - $6.56 Million
833,891 Added 80.44%
1,870,583 $11.2 Million
Q4 2020

Feb 12, 2021

SELL
$5.25 - $8.56 $2.69 Million - $4.39 Million
-512,363 Reduced 33.08%
1,036,692 $7.17 Million
Q3 2020

Nov 16, 2020

SELL
$5.78 - $7.47 $3.37 Million - $4.36 Million
-583,374 Reduced 27.36%
1,549,055 $9.7 Million
Q2 2020

Aug 14, 2020

SELL
$4.5 - $7.02 $1.19 Million - $1.85 Million
-263,659 Reduced 11.0%
2,132,429 $14.1 Million
Q1 2020

May 15, 2020

BUY
$2.87 - $5.49 $6.88 Million - $13.2 Million
2,396,088 New
2,396,088 $11.1 Million
Q3 2019

Nov 14, 2019

SELL
$4.86 - $6.05 $1.93 Million - $2.41 Million
-397,973 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$4.51 - $6.6 $1.9 Million - $2.79 Million
-422,170 Reduced 51.48%
397,973 $2.24 Million
Q1 2019

May 13, 2019

BUY
$5.16 - $6.85 $4.23 Million - $5.62 Million
820,143 New
820,143 $5.11 Million

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $294M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Kennedy Capital Management, Inc. Portfolio

Follow Kennedy Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.